CERS:NASDAQ
Cerus Corp
US$2,30
arrow_upward
+0,88%(+0,020) 1D
US$2,30
0,00% (0,00)
bedtimeAfter hours
Closed: 9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CERS...
Open
US$2,31
High
US$2,33
Low
US$2,27
Mkt. cap
463,51 ລ້ານ
Avg. vol.
1,65 ລ້ານ
Volume
787,96 ພັນ
52-wk high
US$3,47
52-wk low
US$1,38
EPS
US$-0,03
Beta
1,83
Shares outstanding
201,52 ລ້ານ
No. of employees
268
Open
US$2,31
High
US$2,33
Low
US$2,27
Mkt. cap
463,51 ລ້ານ
Avg. vol.
1,65 ລ້ານ
Volume
787,96 ພັນ
52-wk high
US$3,47
52-wk low
US$1,38
EPS
US$-0,03
Beta
1,83
Shares outstanding
201,52 ລ້ານ
No. of employees
268
News stories
From web sources and news partners
Business Wire
·
1 ຊົ່ວໂມງກ່ອນ
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
Nasdaq
·
26 ນາທີກ່ອນ
Chartstopper: October 9, 2026
GuruFocus
·
59 ນາທີກ່ອນ
Nasdaq CEO Flags Tens of Billions in New Wall Street Opportunity
Yahoo Finance
·
5 ຊົ່ວໂມງກ່ອນ
Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
Profile
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
About Cerus Corp
CEO-
Employees268
Foundedກ.ຍ. 1991
HeadquartersConcord, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorMedical device
Websitecerus.com